Electronic Batch Records (eBR) turn manufacturing instructions into controlled digital workflows, capture shop-floor execution and consolidate data from multiple systems into the batch record. Historically, regulatory attention focused on validating the application and proving that it performed intended GMP functions consistently.[1]
With the advent of newer technologies andarchitectural complexities, that model is no longer sufficient. Modern eBR platforms connect PLCs, historians, weighing systems, LIMS, ERP, databases, cloud infrastructure, identity platforms, and many more custom interfaces. Manufacturersare also adopting SaaS and modern cybersecurity controls while defining ho technology can be used without compromising ALCOA++ principles.
The European Commission’s July 2025 draft revision of Annex 11[2] expands expectations for lifecycle management,supplier oversight, data integrity, security, and computerized-system infrastructure. For eBR implementations, three themes stand out: cybersecurity, SaaS and data integrity.
These are not isolated compliance checks; the article aims at reviewing in what way they could reshape how eBR solutions are designed, implemented, and supported and what customers expect from system integrators.
1. Cybersecurity Moves Closer to the GMP Core
Cybersecurity has traditionally been treated as an IT responsibility, covaering firewalls, segmentation, access management,patching, vulnerability management, and monitoring, while validation teams focused on intended GMP functions. In a connected manufacturing environment,that separation is increasingly difficult to maintain and recognize.
The proposed Annex 11 requires strongerprotection for GMP systems, networks and infrastructure, as well as ongoing measures to address evolving cybersecurity threats. The key question for service providers becomes: Can the environment, not only the application, maintain the GMP validated state?
Routine infrastructure changes including data base patches, firewall rules, operating-system upgrades or certificates may originate outside the eBR yet may affect how the eBR behaves, making validation a continuous task: the applicationmust remain controlled as its environment evolves.
For manufacturers, this requires closer collaboration among Manufacturing IT, Quality, Validation and Cybersecurity. For integrators, the role expands beyond implementation and handover to helping customers assess how technology changes may affect the solution’s GMP state.
2. SaaS Changes the Meaning of "Where the System Lives"
Cloud and Software-as-a-Service introduce a second major shift. Pharmaceutical companies once hosted manufacturing applications on infrastructure they owned usually in a secluded refrigerated room not really known by many.
With SaaS, the software provider may host the application on infrastructure managed by third-party suppliers. Although responsibilities are shared across these parties, the regulated manufacturer remains ultimately accountable for compliance. [2 – 6.3]
The proposed Annex 11 recognizes cloud services and strengthens expectations for outsourced activities. Regulated users must retain sufficient oversight and evidence, making supplier qualification, contracts, service levels, change notification, incident management, documentation, and inspection access central to compliance.
The eBR integrator becomes a bridge among manufacturers, operations teams, cloud providers, cybersecurity organizations, quality,and validation. This requires understanding the broader technology stack and coordinating impact assessment, testing, evidence, and customer communication when infrastructure changes could affect the validated state.
This creates an opportunity for integrators to evolve from implementation consultants into lifecycle technology partners: future eBR projects may look less like software installations and more like ecosystem implementations.
3. Data Integrity Becomesan Stringent Requirement
Data integrity may be the most underestimated challenge deriving from the increased complexity of the architectures. An eBR may receive process data from PLCs and SCADA, materials from ERP, results from LIMS, weights from scales, and so on. Each source may use different data models, numeric representations, time stamps, units, precision, or database technologies: small technical differences can therefore become GMP concerns.
For example, a source system may store a double-precision value, an interface may convert it to fixed-point represented value and the receiving application may display fewer decimals as a result.That may appear cosmetic, but it becomes a data-integrity issue if the value supports calculations or specification checks and the original, transferred, and displayed values no longer align.
The proposed revision gives greater weight to lifecycle data integrity and connects ALCOA+ to data handling and audit trails. For eBR, integrity cannot be assessed independently from feeder systems: transformations, precision changes, timestamp conversions and derived datamust be understood, justified, validated, approved and traceable.
Data integrity is becomingan integration mindset, and interfaces are not merely technical connections; vthey are part of the GMP data chain and must be designed and controlled accordingly.
The New Role of the System Integrator
These developments point to a broader change: future system integrators must combine eBR configuration expertise with knowledge across several domains:
- Manufacturing processes
- eBR application architecture
- Automation and shop-floor systems
- IT infrastructure
- Cloud marchitecture
- Cybersecurity
- Data engineering
- Integration technologies
- Validation and qualification
- Data integrity
- Supplier and service management
Not every consultant must master every discipline, but successful projects increasingly require people who can connect manufacturing and IT, understanding GMP critical operations and the effects of any IT infrastructure update.
The integrator goal becomes to create acontrolled environment with consistent, repeatable behavior across the ecosystem: numbers and timestamps should be handled as intended, securityupdates should not introduce unintended changes, cloud services should operate within agreed boundaries and controlled inputs should produce reliableresults. In a regulated environment, predictability is a strength.
The proposed Annex 11 revision reflects abroader reality: the computerized system supporting pharmaceutical manufacturing is no longer seen as a series of single applications, but acomplex interlaced ecosystem and the eBR is becoming part of the manufacturing architecture itself.
Manufacturers preparing for the new direction must look beyond individual applications and assess the complete supporting GMP activities. Integrators must understand not only how to configure and validate eBR, but also how it behaves in a connected, continuously changing environment.
Success will therefore mean more than a system that works on validation day. It will mean rolling out an ecosystem, that remains predictable, secure and supported by trust worthy data throughout its lifecycle. That may be the most important change of all, planned to be soon formally defined in the EU Annex 11.
[1] - EU Annex 11 – Current 2011 version https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf
[2] - Draft to EU Annex 11 – Update 2026 https://health.ec.europa.eu/document/download/40231f18-e564-4043-94de-c031f813d38b_en?filename=mp_vol4_chap4_annex11_consultation_guideline_en.pdf
